NDC 0641-6106-01 - Robinul
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6106
- Requested NDC
- 0641-6106-01
- Package NDCs from labels
- 0641-6106-01, 0641-6106-25
- Manufacturer
- West-Ward Pharmaceuticals Corp.
- Effective date
- 2017-06-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ROBINUL Injection (glycopyrrolate injection, USP) | West-Ward Pharmaceuticals Corp. | 2017-06-29 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6106-01 | ML - Milliliter | 0641-6106 | b47f4432-2d77-4c3a-917d-adfe42a4e07a | 1 | 2013-02-13 |
| 0641-6106-25 | ML - Milliliter | 0641-6106 | addaf8ca-8bf3-4621-a321-d03010ca232b | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GLYCOPYRROLATE | ACTIVE INGREDIENT | V92SO9WP2I | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| GLYCOPYRROLATE | ACTIVE MOIETY | V92SO9WP2I | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 54458620-d888-4df6-ae4b-78c3dfed3423 | 2023-08-16 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 88d3e865-8dca-4c89-b6f7-a34c481f75b9 | 2023-08-16 | Warnings, Adverse reactions | V92SO9WP2I |
| REFL HS | ADENOSINUM TRIPHOSPHORICUM DINATRUM, NADIDUM, ARGENTUM NITRICUM, IPECACUANHA, ROBINIA PSEUDOACACIA, SULPHUR, ORIGANUM VULGARE, DUODENUM (SUIS), ESOPHAGUS (SUIS), FUNICULUS UMBILICALIS SUIS, STOMACH (SUIS), NUX VOMICA, COUMARINUM, ERYTHRAEA CENTAURIUM, PANCREATINUM, MURIATICUM ACIDUM, CITRICUM ACIDUM, FORMICUM ACIDUM, SARCOLACTICUM ACIDUM, COENZYME A, PROTEUS (MORGANI) | Deseret Biologicals, Inc. | 2fe2d3c1-1829-4a33-be8e-2bad52546f36 | 2023-07-17 | Warnings | QTT17582CB |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | 4c733750-45fe-4876-8e4f-c61c52470405 | 2023-06-06 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 86abf577-562c-5eb1-e053-2a91aa0ac10f | 2023-06-01 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 66726c2b-27e8-5dd1-e053-2991aa0a1ba7 | 2023-06-01 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 69353cc1-f5d4-170b-e053-2a91aa0ad5a5 | 2023-05-23 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 6934f467-949f-97cc-e053-2a91aa0a05fb | 2023-05-23 | Warnings, Adverse reactions | V92SO9WP2I |
| Bacteriostatic Water | WATER | Medical Purchasing Solutions, LLC | 69485218-9343-952d-e053-2a91aa0ad4e8 | 2023-05-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 95fbe384-eaff-1f2e-e053-2a95a90a0313 | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f126596-7fbf-7a48-e053-2995a90abac7 | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f12016d-9033-00b4-e053-2a95a90ad02a | 2023-05-15 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 9c9666bf-841b-03fa-e053-2a95a90abb48 | 2023-05-11 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 9e5113b7-1c0c-24bd-e053-2995a90ab94b | 2023-05-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Sterile Water | STERILE WATER | Hikma Pharmaceuticals USA Inc. | b20a28b0-7dfa-42eb-9177-ec256d5a5ef7 | 2023-05-08 | Warnings, Adverse reactions | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | bbf0abe2-8deb-19b2-e053-2a95a90a60a3 | 2023-05-08 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | b622f21f-fa37-1259-e053-2995a90aa796 | 2023-05-04 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | a2a2a03f-21cc-5fec-e053-2995a90a84cb | 2023-05-03 | Warnings, Adverse reactions | V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.